GADOBUTROL

GADOBUTROL was reported 4907 times

GADOBUTROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NONTHERAPEUTIC AGENT URINE POSITIVE 54 0.5294
1 NONTHERAPEUTIC AGENT BLOOD POSITIVE 10 0.3571
2 BRIEF PSYCHOTIC DISORDER WITHOUT MARKED STRESSORS 1 0.2500
3 HEAVY METAL ABNORMAL 3 0.2308
4 CONTRAST MEDIA TOXICITY 29 0.2283
5 GADOLINIUM DEPOSITION DISEASE 97 0.1754
6 CONTRAST MEDIA DEPOSITION 53 0.1683
7 SCAN WITH CONTRAST 3 0.1579
8 BLOOD HEAVY METAL ABNORMAL 2 0.1538
9 HEAVY METAL INCREASED 3 0.1364
10 CYTOKINE INCREASED 14 0.1037
11 ALK GENE REARRANGEMENT POSITIVE 1 0.1000
12 BLOOD HEAVY METAL INCREASED 5 0.0714
13 CONTRAST MEDIA REACTION 168 0.0711
14 CRAMP-FASCICULATION SYNDROME 2 0.0667
15 HAIR METAL TEST ABNORMAL 2 0.0645
16 CONTRAST MEDIA ALLERGY 115 0.0627
17 MUCOSAL IRRITATION 2 0.0606
18 STERTOR 2 0.0571
19 BILE OUTPUT DECREASED 1 0.0435
20 MUSCLE FIBROSIS 3 0.0411
21 BIOPSY THYROID GLAND ABNORMAL 1 0.0400
22 GINGIVAL PRURITUS 3 0.0349
23 OXYGEN SATURATION IMMEASURABLE 3 0.0273
24 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 2 0.0244
25 SCLERAL OEDEMA 2 0.0241
26 HYPERINTENSITY IN BRAIN DEEP NUCLEI 2 0.0238
27 PERIHEPATIC DISCOMFORT 2 0.0230
28 PARAESTHESIA MUCOSAL 2 0.0215
29 BIOPSY BRAIN ABNORMAL 1 0.0200
30 BLOOD CATECHOLAMINES DECREASED 1 0.0196
31 MITOCHONDRIAL TOXICITY 16 0.0195
32 DRUG CROSS-REACTIVITY 3 0.0168
33 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 1 0.0152
34 OPTIC NERVE COMPRESSION 2 0.0146
35 CONTRAST ENCEPHALOPATHY 4 0.0145
36 METAL POISONING 8 0.0138
37 PARAESTHESIA EAR 2 0.0136
38 SMALL FIBRE NEUROPATHY 10 0.0136
39 PROSOPAGNOSIA 2 0.0125
40 BONE HYPERTROPHY 2 0.0124
41 SKIN FIBROSIS 6 0.0124
42 BURKHOLDERIA INFECTION 1 0.0120
43 CIRCUMORAL OEDEMA 4 0.0115
44 THYMUS DISORDER 2 0.0105
45 BLOOD CORTICOTROPHIN ABNORMAL 1 0.0104
46 SICCA SYNDROME 2 0.0104
47 AUTOIMMUNE ENCEPHALOPATHY 1 0.0099
48 LOSS OF PROPRIOCEPTION 3 0.0093
49 HEMIANAESTHESIA 7 0.0088
50 LARYNX IRRITATION 2 0.0085
51 BIOPSY SKIN ABNORMAL 2 0.0083
52 CALCIUM IONISED DECREASED 2 0.0082
53 MYOSCLEROSIS 3 0.0081
54 BURKHOLDERIA TEST POSITIVE 1 0.0081
55 NASAL PRURITUS 10 0.0080
56 INCISION SITE DISCHARGE 2 0.0079
57 VIBRATORY SENSE INCREASED 2 0.0079
58 SUPERFICIAL VEIN PROMINENCE 2 0.0078
59 AORTIC INTRAMURAL HAEMATOMA 1 0.0077
60 BLOOD PRESSURE IMMEASURABLE 11 0.0072
61 URTICARIA 1188 0.0071
62 TONGUE PRURITUS 6 0.0070
63 NEPHROGENIC SYSTEMIC FIBROSIS 21 0.0069
64 MITOCHONDRIAL CYTOPATHY 3 0.0068
65 RESPIRATORY TRACT OEDEMA 5 0.0067
66 SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG 2 0.0065
67 FOAMING AT MOUTH 13 0.0064
68 SKIN TEST POSITIVE 6 0.0064
69 SNEEZING 141 0.0063
70 NON-CARDIOGENIC PULMONARY OEDEMA 6 0.0057
71 BURNING SENSATION MUCOSAL 2 0.0057
72 ORAL PRURITUS 13 0.0057
73 URINARY TRACT INFLAMMATION 2 0.0056
74 TRANCE 2 0.0055
75 PANCREATIC ENLARGEMENT 2 0.0054
76 NEUROBLASTOMA 2 0.0052
77 ADMINISTRATION RELATED REACTION 1 0.0051
78 URINE ANALYSIS ABNORMAL 15 0.0050
79 PERIPHERAL CIRCULATORY FAILURE 2 0.0049
80 VOMITING PROJECTILE 14 0.0048
81 BREAST NECROSIS 1 0.0048
82 LIP PRURITUS 4 0.0047
83 HAEMANGIOMA OF SKIN 2 0.0046
84 HYPERAEMIA 9 0.0046
85 MUSCLE CONTRACTIONS INVOLUNTARY 16 0.0045
86 THROAT TIGHTNESS 120 0.0044
87 PHARYNGEAL PARAESTHESIA 7 0.0044
88 SUSPECTED PRODUCT QUALITY ISSUE 8 0.0044
89 EAR PRURITUS 15 0.0043
90 MASTOCYTOSIS 2 0.0042
91 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 6 0.0041
92 THROAT IRRITATION 184 0.0041
93 SENSORIMOTOR DISORDER 2 0.0040
94 URINARY TRACT PAIN 2 0.0040
95 ORBITAL OEDEMA 2 0.0040
96 B-CELL APLASIA 1 0.0039
97 SKIN CANDIDA 2 0.0038
98 OROPHARYNGEAL DISCOMFORT 34 0.0038
99 PULSE ABNORMAL 9 0.0037
100 JOINT CONTRACTURE 4 0.0037
101 BLOOD GASES ABNORMAL 2 0.0037
102 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
103 HYPERTROPHY 2 0.0037
104 PILOERECTION 4 0.0037
105 BLOOD PH INCREASED 2 0.0036
106 SKIN HYPERTROPHY 10 0.0036
107 AGONAL RESPIRATION 1 0.0035
108 SEIZURE LIKE PHENOMENA 6 0.0035
109 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
110 LARYNGEAL STENOSIS 2 0.0035
111 ALLODYNIA 4 0.0034
112 DOSE CALCULATION ERROR 2 0.0034
113 HYPOAESTHESIA EYE 2 0.0034
114 EAR SWELLING 7 0.0033
115 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
116 MEAN CELL VOLUME DECREASED 5 0.0032
117 VASCULAR PAIN 3 0.0031
118 LARYNGEAL DISCOMFORT 2 0.0031
119 SUBCUTANEOUS HAEMATOMA 4 0.0031
120 BLADDER IRRITATION 2 0.0031
121 DRUG CLEARANCE DECREASED 4 0.0031
122 INJECTION RELATED REACTION 5 0.0030
123 SPUTUM RETENTION 3 0.0030
124 SPUTUM ABNORMAL 2 0.0030
125 BLOOD VISCOSITY DECREASED 1 0.0030
126 CONJUNCTIVAL OEDEMA 3 0.0029
127 HYPOPERFUSION 3 0.0029
128 ANOXIA 1 0.0028
129 PERINEAL PAIN 2 0.0028
130 GALLBLADDER ENLARGEMENT 3 0.0028
131 SKIN WARM 16 0.0027
132 PULSE ABSENT 13 0.0027
133 EYE SWELLING 100 0.0027
134 BRAIN STEM SYNDROME 2 0.0027
135 ANISOCORIA 1 0.0026
136 SENSATION OF FOREIGN BODY 22 0.0026
137 CARBON DIOXIDE DECREASED 3 0.0026
138 ADMINISTRATION SITE REACTION 1 0.0026
139 ANAPHYLACTIC SHOCK 66 0.0026
140 SKIN TIGHTNESS 12 0.0025
141 MUSCLE DISCOMFORT 2 0.0025
142 ASTROCYTOMA 1 0.0025
143 ANAPHYLACTIC REACTION 139 0.0025
144 PROCEDURAL NAUSEA 2 0.0025
145 ANHIDROSIS 1 0.0025
146 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
147 LARYNGEAL OEDEMA 15 0.0024
148 LIP DISCOLOURATION 3 0.0024
149 AMAUROSIS 2 0.0024
150 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
151 INJECTION SITE COLDNESS 2 0.0024
152 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
153 FEELING HOT 142 0.0023
154 UNRESPONSIVE TO STIMULI 59 0.0023
155 NASAL OEDEMA 4 0.0022
156 ALLERGY TEST POSITIVE 1 0.0022
157 ANTI-THYROID ANTIBODY POSITIVE 1 0.0022
158 PHARYNGEAL HYPOAESTHESIA 2 0.0022
159 ELECTRIC SHOCK SENSATION 6 0.0021
160 ADRENAL NEOPLASM 1 0.0021
161 GENERALISED ERYTHEMA 12 0.0021
162 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
163 SKIN TEXTURE ABNORMAL 2 0.0021
164 FINE MOTOR SKILL DYSFUNCTION 6 0.0021
165 IDIOSYNCRATIC DRUG REACTION 2 0.0020
166 STRIDOR 6 0.0020
167 MUSCLE TWITCHING 47 0.0020
168 ARTERIOVENOUS FISTULA 1 0.0020
169 LIP SWELLING 67 0.0020
170 SALIVARY HYPERSECRETION 20 0.0020
171 RENAL PAIN 21 0.0020
172 EYELID OEDEMA 23 0.0020
173 SUSPECTED PRODUCT CONTAMINATION 2 0.0020
174 PERIORBITAL SWELLING 11 0.0019
175 PHARYNGEAL SWELLING 19 0.0019
176 SKIN INDURATION 4 0.0019
177 CONSCIOUSNESS FLUCTUATING 2 0.0019
178 PRURITUS 730 0.0019
179 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
180 EXOPHTHALMOS 4 0.0019
181 IRON OVERLOAD 2 0.0019
182 ERYTHEMA 375 0.0018
183 CHOKING SENSATION 10 0.0018
184 RESUSCITATION 3 0.0018
185 BLOOD MAGNESIUM ABNORMAL 1 0.0018
186 PARAESTHESIA ORAL 26 0.0018
187 BONE FRAGMENTATION 1 0.0018
188 BURNOUT SYNDROME 1 0.0018
189 COLD SWEAT 31 0.0018
190 PHARYNGEAL OEDEMA 27 0.0018
191 CORTISOL DECREASED 2 0.0017
192 PO2 DECREASED 2 0.0017
193 EXTREMITY NECROSIS 3 0.0017
194 PRURITUS GENERALISED 37 0.0017
195 TYPE I HYPERSENSITIVITY 6 0.0017
196 EXTRAVASATION 7 0.0017
197 PUSTULE 4 0.0017
198 PRESYNCOPE 41 0.0017
199 AGRAPHIA 1 0.0017
200 MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0017
201 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
202 SCLERODERMA 6 0.0016
203 VESTIBULAR DISORDER 2 0.0016
204 PALLOR 44 0.0016
205 EYE MOVEMENT DISORDER 11 0.0016
206 THROAT CLEARING 6 0.0016
207 NASAL OBSTRUCTION 3 0.0016
208 SWELLING OF EYELID 10 0.0016
209 CYANOSIS 25 0.0016
210 TESTICULAR SWELLING 2 0.0016
211 VOMITING 742 0.0016
212 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 12 0.0015
213 SLOW RESPONSE TO STIMULI 2 0.0015
214 JOINT NOISE 3 0.0015
215 HYPOAESTHESIA ORAL 23 0.0015
216 EYE PRURITUS 51 0.0015
217 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
218 ANION GAP INCREASED 2 0.0015
219 TACHYPNOEA 20 0.0015
220 CORNEAL OPACITY 2 0.0015
221 RESPIRATORY RATE INCREASED 13 0.0015
222 ANAPHYLACTOID REACTION 6 0.0015
223 PUSTULAR PSORIASIS 5 0.0015
224 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
225 PERIPHERAL ARTERY OCCLUSION 2 0.0014
226 BORDERLINE PERSONALITY DISORDER 1 0.0014
227 CONNECTIVE TISSUE DISORDER 2 0.0014
228 SWELLING FACE 91 0.0014
229 BURNING SENSATION 98 0.0014
230 BRONCHIAL WALL THICKENING 1 0.0014
231 LANGUAGE DISORDER 3 0.0014
232 ACCOMMODATION DISORDER 1 0.0014
233 MUSCLE TIGHTNESS 22 0.0014
234 AXILLARY PAIN 2 0.0013
235 MENTAL FATIGUE 2 0.0013
236 HYPOSMIA 2 0.0013
237 BASOPHIL COUNT INCREASED 1 0.0013
238 ALLERGIC COUGH 1 0.0013
239 RENAL FUNCTION TEST ABNORMAL 6 0.0013
240 DRY THROAT 13 0.0013
241 BREAST CALCIFICATIONS 1 0.0013
242 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
243 OEDEMA MOUTH 4 0.0012
244 RETCHING 26 0.0012
245 SUFFOCATION FEELING 3 0.0012
246 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
247 RESPIRATORY DISTRESS 33 0.0012
248 ACUTE RESPIRATORY DISTRESS SYNDROME 21 0.0012
249 SENSORY DISTURBANCE 19 0.0012
250 TONGUE DISCOMFORT 5 0.0012
251 APTYALISM 1 0.0012
252 PHYSICAL DECONDITIONING 3 0.0012
253 TENSION HEADACHE 5 0.0012
254 FIXED ERUPTION 2 0.0012
255 OCULAR HYPERAEMIA 55 0.0012
256 LACRIMATION INCREASED 35 0.0012
257 BLOOD CHLORIDE INCREASED 2 0.0012
258 SWOLLEN TONGUE 36 0.0012
259 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
260 GASTROINTESTINAL OEDEMA 2 0.0011
261 FACE OEDEMA 19 0.0011
262 INFUSION SITE EXTRAVASATION 7 0.0011
263 NAUSEA 890 0.0011
264 SKIN DISCOMFORT 3 0.0011
265 ARTERIOVENOUS MALFORMATION 1 0.0011
266 FLUSHING 112 0.0011
267 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
268 DISORGANISED SPEECH 2 0.0011
269 BRAIN FOG 17 0.0011
270 PRODUCT USE COMPLAINT 17 0.0011
271 LYMPH NODE PAIN 2 0.0011
272 HYPERACUSIS 4 0.0011
273 RASH MACULAR 37 0.0011
274 RESPIRATORY SYMPTOM 3 0.0011
275 MENOMETRORRHAGIA 2 0.0010
276 SKIN MASS 7 0.0010
277 PHARYNGEAL DISORDER 3 0.0010
278 HEAD DISCOMFORT 18 0.0010
279 HYPERVOLAEMIA 5 0.0010
280 CHEST DISCOMFORT 103 0.0010
281 RASH ERYTHEMATOUS 48 0.0010
282 NASAL CONGESTION 59 0.0010
283 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
284 BRAIN HYPOXIA 1 0.0010
285 MUCOSAL DRYNESS 2 0.0010
286 MUSCLE CONTRACTURE 2 0.0010
287 TINNITUS 45 0.0010
288 DYSAESTHESIA 3 0.0010
289 FIBROSIS 3 0.0010
290 HYPERAESTHESIA 8 0.0010
291 TONGUE BITING 2 0.0010
292 ALVEOLITIS ALLERGIC 1 0.0010
293 BODY TEMPERATURE FLUCTUATION 2 0.0010
294 SHOCK 22 0.0010
295 MUSCLE ATROPHY 12 0.0009
296 MUSCLE FATIGUE 4 0.0009
297 PHARYNGEAL ERYTHEMA 2 0.0009
298 TORTICOLLIS 2 0.0009
299 ORAL DISCOMFORT 13 0.0009
300 BLOOD PRESSURE DECREASED 62 0.0009
301 HYPERPHOSPHATAEMIA 2 0.0009
302 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
303 BRONCHOSPASM 13 0.0009
304 PHYSICAL DISABILITY 4 0.0009
305 BONE PAIN 53 0.0009
306 APNOEA 7 0.0009
307 PARESIS 2 0.0009
308 TEMPERATURE REGULATION DISORDER 2 0.0009
309 TASTE DISORDER 18 0.0009
310 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
311 READING DISORDER 2 0.0009
312 RESPIRATORY ARREST 24 0.0009
313 ADMINISTRATION SITE PAIN 1 0.0009
314 PARAESTHESIA 136 0.0009
315 HYPERHIDROSIS 110 0.0009
316 CONJUNCTIVAL HYPERAEMIA 3 0.0008
317 MEDICATION RESIDUE PRESENT 4 0.0008
318 DYSPHONIA 49 0.0008
319 OXYGEN SATURATION DECREASED 47 0.0008
320 BRONCHIAL HYPERREACTIVITY 1 0.0008
321 PAINFUL RESPIRATION 2 0.0008
322 COUGH 231 0.0008
323 FOOD INTOLERANCE 3 0.0008
324 EYE OEDEMA 2 0.0008
325 VITREOUS FLOATERS 8 0.0008
326 CARDIAC ARREST 67 0.0008
327 PULMONARY OEDEMA 36 0.0008
328 DYSPNOEA 455 0.0008
329 ALLERGY TO CHEMICALS 1 0.0008
330 SNORING 3 0.0008
331 WHEEZING 47 0.0008
332 CHEMICAL BURN OF SKIN 2 0.0008
333 BRONCHIAL SECRETION RETENTION 1 0.0008
334 CANCER PAIN 2 0.0008
335 DYSPHAGIA 74 0.0008
336 ADENOCARCINOMA PANCREAS 1 0.0008
337 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
338 RASH GENERALISED 20 0.0008
339 PERIORBITAL OEDEMA 4 0.0008
340 CARDIOPULMONARY FAILURE 3 0.0008
341 URINE OUTPUT INCREASED 2 0.0008
342 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
343 HYPERSENSITIVITY VASCULITIS 2 0.0008
344 YAWNING 2 0.0007
345 FLANK PAIN 7 0.0007
346 TRIGEMINAL NEURALGIA 3 0.0007
347 HYPERLACTACIDAEMIA 2 0.0007
348 LARYNGOSPASM 2 0.0007
349 BLOOD SODIUM INCREASED 2 0.0007
350 HEART RATE DECREASED 26 0.0007
351 ERYTHEMA OF EYELID 4 0.0007
352 EAR CONGESTION 2 0.0007
353 CLONUS 2 0.0007
354 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
355 BRONCHIAL OBSTRUCTION 1 0.0007
356 ALVEOLITIS 1 0.0007
357 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
358 AUDITORY DISORDER 1 0.0007
359 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
360 OXYGEN SATURATION ABNORMAL 2 0.0007
361 HEPATIC PAIN 3 0.0007
362 HYPOTONIA 7 0.0007
363 NEUROLOGICAL SYMPTOM 4 0.0007
364 ABNORMAL SENSATION IN EYE 3 0.0007
365 MOUTH SWELLING 4 0.0007
366 PARAPLEGIA 2 0.0007
367 PANIC REACTION 5 0.0007
368 VISUAL FIELD DEFECT 5 0.0007
369 TONGUE DISORDER 5 0.0007
370 PULMONARY PAIN 2 0.0007
371 EAR DISCOMFORT 7 0.0007
372 URINARY INCONTINENCE 20 0.0007
373 FACIAL PAIN 6 0.0007
374 CARDIO-RESPIRATORY ARREST 28 0.0007
375 BRAIN HERNIATION 2 0.0007
376 COGNITIVE DISORDER 31 0.0007
377 EMERGENCY CARE 2 0.0007
378 ACIDOSIS 5 0.0007
379 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
380 SYNCOPE 65 0.0006
381 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
382 ERYTHEMA MULTIFORME 6 0.0006
383 BRONCHIAL DISORDER 1 0.0006
384 EYELIDS PRURITUS 2 0.0006
385 RESPIRATORY RATE DECREASED 2 0.0006
386 LOSS OF CONSCIOUSNESS 81 0.0006
387 TESTICULAR PAIN 2 0.0006
388 VENTRICULAR FIBRILLATION 7 0.0006
389 NEUROTOXICITY 11 0.0006
390 NEURALGIA 15 0.0006
391 ASPHYXIA 5 0.0006
392 DISTURBANCE IN ATTENTION 33 0.0006
393 FEELING COLD 17 0.0006
394 BODY TEMPERATURE DECREASED 6 0.0006
395 BRAIN INJURY 6 0.0006
396 CYTOKINE RELEASE SYNDROME 12 0.0006
397 QUALITY OF LIFE DECREASED 8 0.0006
398 HYPOTENSION 119 0.0006
399 CONJUNCTIVITIS 11 0.0006
400 BLOOD PH DECREASED 1 0.0006
401 INCREASED UPPER AIRWAY SECRETION 3 0.0006
402 PERIPHERAL COLDNESS 8 0.0006
403 REGURGITATION 2 0.0006
404 SEIZURE 67 0.0006
405 HYPOPNOEA 2 0.0006
406 FORMICATION 4 0.0006
407 TACHYCARDIA 51 0.0006
408 SKIN BURNING SENSATION 41 0.0006
409 SKIN DISORDER 19 0.0006
410 BLOOD LACTIC ACID INCREASED 3 0.0006
411 GROIN PAIN 5 0.0006
412 SKIN REACTION 8 0.0006
413 PAPULE 4 0.0006
414 INJECTION SITE EXTRAVASATION 7 0.0006
415 BREAST CYST 1 0.0006
416 FIBRIN D DIMER INCREASED 2 0.0006
417 PRODUCT CONTAMINATION 2 0.0006
418 RASH 244 0.0006
419 HYPOAESTHESIA 83 0.0006
420 ASTHMATIC CRISIS 2 0.0005
421 BLOOD PHOSPHORUS DECREASED 2 0.0005
422 VENTRICULAR ARRHYTHMIA 2 0.0005
423 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
424 DYSGEUSIA 40 0.0005
425 AURA 1 0.0005
426 RASH PAPULAR 12 0.0005
427 ACUTE PULMONARY OEDEMA 3 0.0005
428 PROTEIN TOTAL DECREASED 2 0.0005
429 PARANASAL SINUS DISCOMFORT 2 0.0005
430 TENDON PAIN 4 0.0005
431 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
432 SINUS CONGESTION 7 0.0005
433 MUSCULOSKELETAL CHEST PAIN 8 0.0005
434 RALES 3 0.0005
435 SPINAL CORD COMPRESSION 2 0.0005
436 HYPOXIA 18 0.0005
437 HEPATOMEGALY 5 0.0005
438 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
439 DISORIENTATION 20 0.0005
440 AZOTAEMIA 2 0.0005
441 SPEECH DISORDER 26 0.0005
442 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
443 BREAST DISORDER 1 0.0005
444 PERIPHERAL ISCHAEMIA 2 0.0005
445 DIZZINESS 244 0.0005
446 HYPERSENSITIVITY 90 0.0005
447 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
448 DRY EYE 24 0.0005
449 RASH PRURITIC 26 0.0005
450 PETECHIAE 5 0.0005
451 SKIN DISCOLOURATION 22 0.0005
452 BRAIN OEDEMA 6 0.0005
453 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
454 LIP OEDEMA 2 0.0005
455 RESPIRATORY DISORDER 14 0.0005
456 METASTATIC NEOPLASM 2 0.0005
457 SWELLING 43 0.0005
458 DYSPHEMIA 2 0.0005
459 MENTAL IMPAIRMENT 11 0.0005
460 CHEST PAIN 84 0.0005
461 GINGIVAL SWELLING 2 0.0005
462 PALPITATIONS 53 0.0005
463 ADVERSE REACTION 6 0.0005
464 WHEELCHAIR USER 2 0.0004
465 BACTERIAL TEST POSITIVE 1 0.0004
466 THIRST 8 0.0004
467 HEART RATE INCREASED 44 0.0004
468 PAPILLOEDEMA 2 0.0004
469 BLOOD LOSS ANAEMIA 1 0.0004
470 RESPIRATORY TRACT CONGESTION 7 0.0004
471 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
472 MICTURITION URGENCY 5 0.0004
473 EAR DISORDER 2 0.0004
474 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
475 RESPIRATION ABNORMAL 3 0.0004
476 LOCALISED OEDEMA 2 0.0004
477 APHASIA 13 0.0004
478 SPINAL PAIN 5 0.0004
479 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
480 DISCOMFORT 26 0.0004
481 PHOTOPHOBIA 8 0.0004
482 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
483 IMPAIRED WORK ABILITY 9 0.0004
484 MUSCULOSKELETAL DISORDER 8 0.0004
485 RASH VESICULAR 2 0.0004
486 RASH PUSTULAR 3 0.0004
487 RASH MACULO-PAPULAR 9 0.0004
488 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
489 TREMOR 67 0.0004
490 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
491 EOSINOPHILIA 7 0.0004
492 LYMPHOCYTE COUNT DECREASED 7 0.0004
493 ECONOMIC PROBLEM 6 0.0004
494 VISUAL IMPAIRMENT 49 0.0004
495 DRUG ERUPTION 7 0.0004
496 CARDIOVASCULAR DISORDER 10 0.0004
497 SUBARACHNOID HAEMORRHAGE 4 0.0004
498 AMMONIA INCREASED 2 0.0004
499 PROCEDURAL COMPLICATION 3 0.0004
500 BLOOD CHLORIDE DECREASED 1 0.0004
501 TEMPERATURE INTOLERANCE 4 0.0004
502 HYPERBILIRUBINAEMIA 4 0.0004
503 FOETAL DEATH 2 0.0004
504 DRUG SCREEN POSITIVE 3 0.0004
505 SERUM FERRITIN INCREASED 2 0.0004
506 NASAL DISCOMFORT 3 0.0004
507 BLOOD ALBUMIN DECREASED 3 0.0004
508 NYSTAGMUS 2 0.0004
509 BLOOD POTASSIUM ABNORMAL 1 0.0004
510 ABDOMINAL MASS 1 0.0004
511 BEHAVIOUR DISORDER 2 0.0004
512 ABDOMINAL RIGIDITY 1 0.0004
513 TIC 2 0.0004
514 MYALGIA 62 0.0004
515 NONSPECIFIC REACTION 2 0.0004
516 ASTHENOPIA 2 0.0004
517 HYPERKERATOSIS 2 0.0004
518 ANGIOEDEMA 16 0.0004
519 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
520 INTRACRANIAL PRESSURE INCREASED 2 0.0004
521 NECK PAIN 20 0.0004
522 HEADACHE 222 0.0004
523 PAIN IN JAW 10 0.0004
524 PARALYSIS 5 0.0003
525 MUSCULOSKELETAL DISCOMFORT 6 0.0003
526 IMPAIRED QUALITY OF LIFE 5 0.0003
527 SKIN ATROPHY 2 0.0003
528 DIPLOPIA 9 0.0003
529 SKIN SWELLING 3 0.0003
530 BILIARY COLIC 1 0.0003
531 MUSCULAR WEAKNESS 39 0.0003
532 JOINT STIFFNESS 9 0.0003
533 SYRINGE ISSUE 6 0.0003
534 HYPOVOLAEMIA 2 0.0003
535 PURPURA 3 0.0003
536 PAIN OF SKIN 9 0.0003
537 POLYNEUROPATHY 4 0.0003
538 OPTIC NEURITIS 3 0.0003
539 TENSION 2 0.0003
540 RESPIRATORY DEPRESSION 4 0.0003
541 ENCEPHALOPATHY 8 0.0003
542 MUSCLE SPASTICITY 4 0.0003
543 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
544 CHILLS 38 0.0003
545 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
546 BLEPHAROSPASM 2 0.0003
547 EYE IRRITATION 18 0.0003
548 MYDRIASIS 4 0.0003
549 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
550 ATELECTASIS 3 0.0003
551 CARDIAC FLUTTER 2 0.0003
552 INCOHERENT 2 0.0003
553 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
554 CHOKING 6 0.0003
555 BACTERIAL SEPSIS 1 0.0003
556 BRADYPHRENIA 2 0.0003
557 BEDRIDDEN 4 0.0003
558 UNEVALUABLE EVENT 23 0.0003
559 DYSGRAPHIA 2 0.0003
560 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
561 BLOOD PRESSURE ABNORMAL 6 0.0003
562 RESPIRATORY FAILURE 22 0.0003
563 PAIN IN EXTREMITY 88 0.0003
564 FEELING ABNORMAL 71 0.0003
565 WRONG PRODUCT ADMINISTERED 2 0.0003
566 HEMIPARESIS 5 0.0003
567 INITIAL INSOMNIA 3 0.0003
568 HOT FLUSH 22 0.0003
569 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
570 ECCHYMOSIS 2 0.0003
571 INJECTION SITE WARMTH 6 0.0003
572 APLASIA PURE RED CELL 1 0.0003
573 APHONIA 4 0.0003
574 SCRATCH 3 0.0003
575 VISION BLURRED 39 0.0003
576 BRADYCARDIA 15 0.0003
577 BLOOD PRESSURE INCREASED 43 0.0003
578 BONE LESION 1 0.0003
579 LEUKOCYTOSIS 5 0.0003
580 DERMATITIS BULLOUS 2 0.0003
581 TOOTHACHE 5 0.0003
582 RESTLESS LEGS SYNDROME 5 0.0003
583 ARRHYTHMIA 13 0.0003
584 RESTLESSNESS 10 0.0003
585 MUSCLE SPASMS 50 0.0003
586 BLINDNESS TRANSIENT 2 0.0003
587 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
588 HYPERTENSIVE CRISIS 3 0.0003
589 MALNUTRITION 3 0.0003
590 OCULAR DISCOMFORT 3 0.0003
591 BLOOD CALCIUM DECREASED 3 0.0003
592 DYSARTHRIA 10 0.0003
593 PAROSMIA 2 0.0003
594 OSTEOPENIA 4 0.0003
595 RHINORRHOEA 17 0.0003
596 VERTIGO 16 0.0003
597 LIPASE INCREASED 2 0.0003
598 INJECTION SITE RASH 8 0.0003
599 AGITATION 19 0.0003
600 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
601 EAR PAIN 5 0.0003
602 PELVIC FRACTURE 2 0.0003
603 ARTHRALGIA 106 0.0003
604 COMA 12 0.0003
605 PRODUCTIVE COUGH 12 0.0003
606 MOBILITY DECREASED 18 0.0003
607 BLOOD PRESSURE FLUCTUATION 6 0.0002
608 ADVERSE EVENT 23 0.0002
609 EYE PAIN 14 0.0002
610 ASTHMA 28 0.0002
611 MUSCLE DISORDER 2 0.0002
612 MUSCLE INJURY 2 0.0002
613 DYSSTASIA 7 0.0002
614 PRODUCT USE ISSUE 45 0.0002
615 POISONING 3 0.0002
616 HAEMODIALYSIS 2 0.0002
617 SKIN PLAQUE 2 0.0002
618 BUNDLE BRANCH BLOCK LEFT 1 0.0002
619 CIRCULATORY COLLAPSE 4 0.0002
620 ABSCESS LIMB 1 0.0002
621 SCAR 4 0.0002
622 SKIN HYPERPIGMENTATION 2 0.0002
623 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
624 ANURIA 2 0.0002
625 ABDOMINAL PAIN 54 0.0002
626 BLOOD MAGNESIUM DECREASED 2 0.0002
627 MYOPATHY 2 0.0002
628 BALANCE DISORDER 20 0.0002
629 PYELONEPHRITIS 2 0.0002
630 PRODUCT PRESCRIBING ISSUE 5 0.0002
631 DEAFNESS 6 0.0002
632 URINE OUTPUT DECREASED 2 0.0002
633 TUMOUR LYSIS SYNDROME 2 0.0002
634 LUNG INFILTRATION 2 0.0002
635 LIMB DISCOMFORT 7 0.0002
636 ASTHENIA 84 0.0002
637 EMOTIONAL DISTRESS 27 0.0002
638 DRY MOUTH 18 0.0002
639 PELVIC PAIN 4 0.0002
640 GINGIVAL BLEEDING 3 0.0002
641 SKIN LESION 6 0.0002
642 INCREASED TENDENCY TO BRUISE 2 0.0002
643 NIGHT SWEATS 7 0.0002
644 MALAISE 95 0.0002
645 PERICARDIAL EFFUSION 5 0.0002
646 ARTHRITIS INFECTIVE 1 0.0002
647 PERSONALITY CHANGE 2 0.0002
648 BLOOD CREATININE INCREASED 14 0.0002
649 BLISTER 12 0.0002
650 BLOOD TEST ABNORMAL 3 0.0002
651 HEPATIC CIRRHOSIS 4 0.0002
652 DISEASE PROGRESSION 25 0.0002
653 SINUS TACHYCARDIA 3 0.0002
654 ANXIETY 60 0.0002
655 CARDIOGENIC SHOCK 3 0.0002
656 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
657 LETHARGY 12 0.0002
658 ACUTE RESPIRATORY FAILURE 4 0.0002
659 INFLUENZA LIKE ILLNESS 17 0.0002
660 LIVER FUNCTION TEST ABNORMAL 6 0.0002
661 DIZZINESS POSTURAL 2 0.0002
662 HAEMORRHOIDS 4 0.0002
663 INJECTION SITE URTICARIA 5 0.0002
664 HYPERTENSION 43 0.0002
665 BREATH SOUNDS ABNORMAL 1 0.0002
666 DISABILITY 4 0.0002
667 SINUS DISORDER 4 0.0002
668 PERIPHERAL SWELLING 31 0.0002
669 AGEUSIA 5 0.0002
670 BONE LOSS 3 0.0002
671 TOXIC SKIN ERUPTION 2 0.0002
672 CONFUSIONAL STATE 32 0.0002
673 ABDOMINAL PAIN LOWER 5 0.0002
674 HYPOTHERMIA 2 0.0002
675 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
676 FEEDING DISORDER 4 0.0002
677 MOTOR DYSFUNCTION 2 0.0002
678 OROPHARYNGEAL PAIN 18 0.0002
679 MUSCULOSKELETAL STIFFNESS 17 0.0002
680 SKIN ULCER 5 0.0002
681 GAIT DISTURBANCE 37 0.0002
682 PANIC ATTACK 7 0.0002
683 DERMATITIS 4 0.0002
684 MEMORY IMPAIRMENT 26 0.0002
685 ANORECTAL DISCOMFORT 1 0.0002
686 METABOLIC ACIDOSIS 6 0.0002
687 BREAST PAIN 2 0.0002
688 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
689 LIVER FUNCTION TEST INCREASED 4 0.0002
690 DECREASED ACTIVITY 2 0.0002
691 INJURY 13 0.0002
692 MULTIPLE FRACTURES 3 0.0002
693 VISUAL ACUITY REDUCED 6 0.0002
694 COAGULOPATHY 3 0.0002
695 MENTAL STATUS CHANGES 5 0.0002
696 NERVE INJURY 2 0.0002
697 BLOOD UREA INCREASED 3 0.0002
698 ANGIOPATHY 1 0.0002
699 NEPHROPATHY TOXIC 2 0.0002
700 STATUS EPILEPTICUS 2 0.0002
701 HEART RATE IRREGULAR 4 0.0002
702 MITRAL VALVE INCOMPETENCE 2 0.0002
703 HAEMATURIA 6 0.0002
704 ANGINA PECTORIS 5 0.0002
705 DELIRIUM 6 0.0002
706 MADAROSIS 2 0.0002
707 NERVOUSNESS 9 0.0002
708 ELECTROLYTE IMBALANCE 2 0.0002
709 VASCULITIS 2 0.0002
710 SPLENOMEGALY 2 0.0002
711 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
712 BRADYKINESIA 1 0.0002
713 GALLBLADDER DISORDER 3 0.0002
714 HYPERLIPIDAEMIA 2 0.0002
715 MUSCLE RIGIDITY 2 0.0002
716 WRIST FRACTURE 2 0.0002
717 HEPATITIS C 2 0.0002
718 BONE DISORDER 3 0.0002
719 HYPERCALCAEMIA 2 0.0002
720 GENERALISED OEDEMA 2 0.0002
721 PHARYNGITIS 2 0.0002
722 PAIN 99 0.0002
723 HEPATIC STEATOSIS 3 0.0002
724 ILEUS 2 0.0002
725 SEPTIC SHOCK 7 0.0002
726 NERVOUS SYSTEM DISORDER 5 0.0002
727 INJECTION SITE DISCOLOURATION 2 0.0002
728 SECRETION DISCHARGE 2 0.0002
729 HAEMATEMESIS 4 0.0002
730 HEPATIC CYTOLYSIS 2 0.0002
731 INTRAOCULAR PRESSURE INCREASED 2 0.0002
732 PULMONARY FIBROSIS 3 0.0002
733 POST PROCEDURAL COMPLICATION 3 0.0002
734 LACTIC ACIDOSIS 5 0.0002
735 AMNESIA 10 0.0002
736 MUSCULOSKELETAL PAIN 8 0.0002
737 ASPERGILLUS INFECTION 1 0.0002
738 EYE DISORDER 5 0.0002
739 IMMUNE SYSTEM DISORDER 2 0.0002
740 PULMONARY CONGESTION 2 0.0002
741 SARS-COV-2 TEST POSITIVE 2 0.0002
742 HAEMATOCRIT DECREASED 3 0.0002
743 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
744 INJECTION SITE PRURITUS 10 0.0001
745 JOINT RANGE OF MOTION DECREASED 2 0.0001
746 BREAST MASS 1 0.0001
747 DYSKINESIA 6 0.0001
748 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
749 PNEUMONITIS 4 0.0001
750 IMPAIRED GASTRIC EMPTYING 2 0.0001
751 ABNORMAL LOSS OF WEIGHT 1 0.0001
752 RIB FRACTURE 3 0.0001
753 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
754 ALOPECIA 28 0.0001
755 HYPERKALAEMIA 5 0.0001
756 BACK PAIN 33 0.0001
757 SEASONAL ALLERGY 2 0.0001
758 LYMPHADENOPATHY 5 0.0001
759 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
760 IRRITABLE BOWEL SYNDROME 3 0.0001
761 RED BLOOD CELL COUNT DECREASED 4 0.0001
762 CONVULSION 8 0.0001
763 HYPERSOMNIA 4 0.0001
764 POOR QUALITY SLEEP 3 0.0001
765 ANOSMIA 2 0.0001
766 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
767 CRYING 5 0.0001
768 ABDOMINAL DISCOMFORT 23 0.0001
769 NEUROPATHY PERIPHERAL 13 0.0001
770 ASCITES 4 0.0001
771 ILLNESS 14 0.0001
772 SKIN HAEMORRHAGE 2 0.0001
773 SOMNOLENCE 27 0.0001
774 GLOSSODYNIA 3 0.0001
775 BLOOD POTASSIUM DECREASED 4 0.0001
776 AORTIC ANEURYSM 1 0.0001
777 RENAL IMPAIRMENT 11 0.0001
778 TENDONITIS 2 0.0001
779 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
780 EJECTION FRACTION DECREASED 2 0.0001
781 MENINGIOMA 2 0.0001
782 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
783 MIGRAINE 12 0.0001
784 ABSCESS 2 0.0001
785 FATIGUE 97 0.0001
786 ACUTE KIDNEY INJURY 19 0.0001
787 OEDEMA PERIPHERAL 15 0.0001
788 CEREBRAL INFARCTION 3 0.0001
789 LIVER INJURY 3 0.0001
790 ABNORMAL FAECES 1 0.0001
791 DYSPEPSIA 12 0.0001
792 ABDOMINAL PAIN UPPER 25 0.0001
793 PHOTOSENSITIVITY REACTION 2 0.0001
794 INJECTION SITE ERYTHEMA 15 0.0001
795 DRUG LEVEL INCREASED 2 0.0001
796 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
797 ACUTE CORONARY SYNDROME 1 0.0001
798 INFUSION RELATED REACTION 8 0.0001
799 RENAL FAILURE 16 0.0001
800 PNEUMONIA ASPIRATION 3 0.0001
801 POLLAKIURIA 5 0.0001
802 GAIT INABILITY 4 0.0001
803 PRODUCT COMPLAINT 3 0.0001
804 HYPOPHAGIA 3 0.0001
805 INSOMNIA 31 0.0001
806 INFLAMMATION 6 0.0001
807 HAEMATOMA 3 0.0001
808 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
809 BLOOD CALCIUM INCREASED 1 0.0001
810 PANCREATITIS 6 0.0001
811 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
812 FEAR 3 0.0001
813 BLOOD BILIRUBIN INCREASED 3 0.0001
814 LIMB INJURY 3 0.0001
815 PYREXIA 38 0.0001
816 END STAGE RENAL DISEASE 2 0.0001
817 ACCIDENTAL OVERDOSE 4 0.0001
818 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
819 MYOCARDIAL INFARCTION 19 0.0001
820 BRAIN NEOPLASM 1 0.0001
821 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
822 DYSURIA 4 0.0001
823 HAEMOPTYSIS 3 0.0001
824 THINKING ABNORMAL 2 0.0001
825 MIDDLE INSOMNIA 2 0.0001
826 TOXICITY TO VARIOUS AGENTS 18 0.0001
827 HYPOCALCAEMIA 2 0.0001
828 FOOT FRACTURE 2 0.0001
829 ABDOMINAL DISTENSION 11 0.0001
830 BLOOD URINE PRESENT 2 0.0001
831 SLEEP APNOEA SYNDROME 2 0.0001
832 INJECTION SITE SWELLING 8 0.0001
833 DYSTONIA 2 0.0001
834 KIDNEY INFECTION 2 0.0001
835 LABORATORY TEST ABNORMAL 3 0.0001
836 ADVERSE DRUG REACTION 9 0.0001
837 SLEEP DISORDER 7 0.0001
838 NEUTROPHIL COUNT DECREASED 4 0.0001
839 TOOTH LOSS 2 0.0001
840 DIARRHOEA 62 0.0001
841 BONE DENSITY DECREASED 3 0.0001
842 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
843 MOVEMENT DISORDER 3 0.0001
844 FAECES DISCOLOURED 2 0.0001
845 OEDEMA 5 0.0001
846 CHRONIC KIDNEY DISEASE 7 0.0001
847 MENTAL DISORDER 4 0.0001
848 IMPAIRED HEALING 3 0.0001
849 OSTEONECROSIS 3 0.0001
850 ASPIRATION 1 0.0001
851 FEBRILE NEUTROPENIA 6 0.0001
852 LIVER DISORDER 4 0.0001
853 TRANSAMINASES INCREASED 2 0.0001
854 URINARY RETENTION 3 0.0001
855 PANCREATITIS ACUTE 2 0.0001
856 CHROMATURIA 2 0.0001
857 NEPHROLITHIASIS 4 0.0001
858 NEOPLASM PROGRESSION 3 0.0001
859 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
860 BACTERAEMIA 1 0.0001
861 PRODUCT PRESCRIBING ERROR 2 0.0001
862 IRRITABILITY 5 0.0001
863 SKIN EXFOLIATION 7 0.0001
864 DRY SKIN 11 0.0001
865 ADRENAL INSUFFICIENCY 1 0.0001
866 LUNG DISORDER 4 0.0001
867 OFF LABEL USE 71 0.0001
868 EPISTAXIS 6 0.0001
869 GASTROINTESTINAL DISORDER 7 0.0001
870 ERECTILE DYSFUNCTION 2 0.0001
871 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
872 ANHEDONIA 2 0.0001
873 JAUNDICE 2 0.0001
874 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
875 BLINDNESS 3 0.0001
876 AKATHISIA 1 0.0001
877 DECREASED APPETITE 17 0.0001
878 OSTEOPOROSIS 3 0.0001
879 PROCEDURAL PAIN 2 0.0001
880 DEPRESSION 16 0.0001
881 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
882 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
883 APATHY 1 0.0001
884 INJECTION SITE PAIN 21 0.0001
885 ACUTE MYOCARDIAL INFARCTION 2 0.0001
886 RENAL INJURY 2 0.0001
887 HEPATIC FAILURE 2 0.0001
888 PRODUCT QUALITY ISSUE 9 0.0001
889 DEATH 57 0.0001
890 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
891 ILL-DEFINED DISORDER 4 0.0001
892 PLEURAL EFFUSION 4 0.0001
893 SUICIDAL IDEATION 6 0.0001
894 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
895 HYPOKALAEMIA 3 0.0001
896 ANKLE FRACTURE 1 0.0001
897 RENAL DISORDER 3 0.0001
898 SEPSIS 7 0.0001
899 CONTUSION 6 0.0001
900 THROMBOSIS 5 0.0001
901 BACK DISORDER 1 0.0001
902 WEIGHT DECREASED 17 0.0001
903 STAPHYLOCOCCAL INFECTION 2 0.0001
904 EXPIRED PRODUCT ADMINISTERED 2 0.0001
905 CELLULITIS 3 0.0001
906 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
907 FLUID RETENTION 3 0.0001
908 ANAEMIA 11 0.0001
909 DEVICE USE ERROR 2 0.0001
910 ECZEMA 3 0.0001
911 AMENORRHOEA 1 0.0001
912 DERMATITIS ATOPIC 3 0.0001
913 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
914 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
915 PLATELET COUNT DECREASED 6 0.0001
916 OVERDOSE 12 0.0001
917 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
918 HYPERGLYCAEMIA 2 0.0001
919 INJECTION SITE MASS 2 0.0001
920 FALL 18 0.0001
921 MEDICATION ERROR 3 0.0001
922 PANCYTOPENIA 3 0.0001
923 HEPATIC FUNCTION ABNORMAL 2 0.0001
924 CEREBROVASCULAR ACCIDENT 9 0.0001
925 DYSPNOEA EXERTIONAL 2 0.0001
926 BLOOD SODIUM DECREASED 1 0.0001
927 FLATULENCE 3 0.0001
928 COLITIS 2 0.0001
929 ACNE 4 0.0001
930 PULMONARY EMBOLISM 5 0.0001
931 DEHYDRATION 7 0.0001
932 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
933 ATRIAL FIBRILLATION 5 0.0001
934 PLASMA CELL MYELOMA 2 0.0001
935 ARTHRITIS 4 0.0001
936 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
937 ABNORMAL BEHAVIOUR 2 0.0001
938 ABORTION SPONTANEOUS 2 0.0000
939 EXTRA DOSE ADMINISTERED 2 0.0000
940 BONE MARROW FAILURE 1 0.0000
941 RHABDOMYOLYSIS 2 0.0000
942 BLOOD GLUCOSE INCREASED 9 0.0000
943 CONDITION AGGRAVATED 14 0.0000
944 DRUG INEFFECTIVE 60 0.0000
945 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
946 COLITIS ULCERATIVE 2 0.0000
947 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
948 THERAPY NON-RESPONDER 2 0.0000
949 APPLICATION SITE PRURITUS 1 0.0000
950 INCORRECT DOSE ADMINISTERED 10 0.0000
951 SKIN IRRITATION 2 0.0000
952 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
953 BLOOD CHOLESTEROL INCREASED 2 0.0000
954 CARDIAC DISORDER 4 0.0000
955 BLOOD GLUCOSE DECREASED 2 0.0000
956 JOINT SWELLING 5 0.0000
957 DRUG INTOLERANCE 4 0.0000
958 HYPOGLYCAEMIA 2 0.0000
959 ABASIA 1 0.0000
960 AGGRESSION 2 0.0000
961 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
962 HAEMOGLOBIN DECREASED 4 0.0000
963 DEPRESSED MOOD 2 0.0000
964 BREAST CANCER FEMALE 1 0.0000
965 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
966 HAEMATOCHEZIA 2 0.0000
967 ARTHROPATHY 2 0.0000
968 STOMATITIS 2 0.0000
969 NASOPHARYNGITIS 6 0.0000
970 WEIGHT INCREASED 7 0.0000
971 PNEUMONIA 10 0.0000
972 HEPATIC ENZYME INCREASED 2 0.0000
973 URINARY TRACT INFECTION 5 0.0000
974 INJECTION SITE REACTION 2 0.0000
975 INFECTION 4 0.0000
976 NO ADVERSE EVENT 5 0.0000
977 CONSTIPATION 6 0.0000
978 THROMBOCYTOPENIA 3 0.0000
979 HALLUCINATION 2 0.0000
980 INJECTION SITE HAEMORRHAGE 2 0.0000
981 CARDIAC FAILURE 2 0.0000
982 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
985 NEUTROPENIA 3 0.0000
986 BREAST CANCER 2 0.0000
987 SINUSITIS 2 0.0000
988 HAEMORRHAGE 2 0.0000
989 DRUG DEPENDENCE 3 0.0000
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
991 PSORIASIS 2 0.0000
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
993 PRODUCT DOSE OMISSION ISSUE 4 0.0000
994 COVID-19 2 0.0000